@prefix bf: <http://id.loc.gov/ontologies/bibframe/> .
@prefix bflc: <http://id.loc.gov/ontologies/bflc/> .
@prefix mads: <http://www.loc.gov/mads/rdf/v1#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://stage.bcld.info/works/36180f95-0887-4f4f-8145-6fc9de24f4d9> a bf:Monograph,
        bf:Text,
        bf:Work ;
    bflc:aap "Pharma marketing and pharmacoeconomics : opportunities, challenges, and the way forward" ;
    bflc:aap-normalized "pharmamarketingandpharmacoeconomics:opportunitieschallengesandthewayforward" ;
    bf:adminMetadata [ a bf:AdminMetadata ;
            bflc:catalogerId "Unknown" ;
            bf:date "2026-09-11" ;
            bf:descriptionAuthentication <http://id.loc.gov/vocabulary/marcauthen/pcc> ;
            bf:descriptionLanguage <http://id.loc.gov/vocabulary/languages/eng> ;
            bf:descriptionLevel <http://id.loc.gov/ontologies/bibframe-2-6-0/> ],
        [ a bf:AdminMetadata ;
            bf:agent <http://id.loc.gov/vocabulary/organizations/cbc> ;
            bf:date "2026-09-11T20:22:55.096065+00:00"^^xsd:dateTime ;
            bf:derivedFrom <http://id.loc.gov/resources/works/23817164> ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/c> ] ;
    bf:classification [ a bf:ClassificationDdc ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dlc> ;
            bf:classificationPortion "338.4/76151" ;
            bf:edition "full" ;
            bf:source [ a bf:Source ;
                    bf:code "23/eng/20241010" ] ],
        [ a bf:ClassificationNlm ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dnlm> ;
            bf:classificationPortion "QV 736.1" ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/uba> ],
        [ a bf:ClassificationLcc ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dlc> ;
            bf:classificationPortion "HD9665.5" ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/uba> ] ;
    bf:content <http://id.loc.gov/vocabulary/contentTypes/txt> ;
    bf:contribution [ a bf:Contribution ;
            bf:agent <http://id.loc.gov/rwo/agents/n2022181746> ;
            bf:role <http://id.loc.gov/vocabulary/relators/edt> ],
        [ a bf:Contribution ;
            bf:agent <http://id.loc.gov/rwo/agents/no2024085806> ;
            bf:role <http://id.loc.gov/vocabulary/relators/edt> ],
        [ a bf:Contribution ;
            bf:agent <http://id.loc.gov/rwo/agents/n2024184151> ;
            bf:role <http://id.loc.gov/vocabulary/relators/edt> ],
        [ a bf:Contribution ;
            bf:agent <http://id.loc.gov/rwo/agents/n2024184148> ;
            bf:role <http://id.loc.gov/vocabulary/relators/edt> ] ;
    bf:hasInstance <https://stage.bcld.info/instances/75273950-219b-43a7-9a7d-d8f014f12756> ;
    bf:language <http://id.loc.gov/vocabulary/languages/eng> ;
    bf:relation [ a bf:Relation ;
            bf:associatedResource <https://stage.bcld.info/works/84f7aecb-eed9-4765-aad5-2c6ca7d39d31> ;
            bf:relationship <http://id.loc.gov/entities/relationships/onlineversion>,
                <http://id.loc.gov/vocabulary/relationship/otherphysicalformat> ] ;
    bf:subject [ a bf:Topic,
                mads:ComplexSubject ;
            rdfs:label "Drug Industry--economics" ;
            bflc:aap-normalized "drugindustryeconomics" ;
            bf:source <http://id.loc.gov/vocabulary/subjectSchemes/mesh> ;
            mads:authoritativeLabel "Drug Industry--economics" ;
            mads:componentList ( [ a mads:Topic ;
                        mads:authoritativeLabel "Drug Industry" ] [ a mads:Topic ;
                        mads:authoritativeLabel "economics" ] ) ],
        [ a bf:Topic,
                mads:ComplexSubject ;
            rdfs:label "Marketing--methods" ;
            bflc:aap-normalized "marketingmethods" ;
            bf:source <http://id.loc.gov/vocabulary/subjectSchemes/mesh> ;
            mads:authoritativeLabel "Marketing--methods" ;
            mads:componentList ( [ a mads:Topic ;
                        mads:authoritativeLabel "Marketing" ] [ a mads:Topic ;
                        mads:authoritativeLabel "methods" ] ) ],
        [ a bf:Topic,
                mads:Topic ;
            rdfs:label "Economics, Pharmaceutical" ;
            bflc:aap-normalized "economicspharmaceutical" ;
            bf:source <http://id.loc.gov/vocabulary/subjectSchemes/mesh> ;
            mads:authoritativeLabel "Economics, Pharmaceutical" ] ;
    bf:summary [ a bf:Summary ;
            rdfs:label "\"The pharmaceutical industry has been the subject of intense public scrutiny due to the high cost of its products, providing many challenges to marketing. With particular emphasis on modeling, methodologies, data sources, and application to real-world dilemmas, this book, Pharma Marketing and Pharmacoeconomics: Opportunities, Challenges, and the Way Forward, provides an overview of the marketing strategies adopted by different pharmaceutical companies. It highlights the major marketing problems that concern the pharmaceutical industry and describes new technologies in the pharma industry that can lead to a more reliable personalized pharma business. This book focuses on providing evidence for the requirement of launching and maintaining a high level of marketing activity for contemporary healthcare organizations that operate in a competitive market environment. It provides reviews of marketing strategies and their effects on the behavior of consumers and physicians. It also highlights the negative impact of these methods, which include disease mongering, misleading advertisements, and escalating the cost of drugs. The chapters of the book illustrate the implication of E-commerce in the healthcare industry with an overview of new funding techniques adopted in the biopharma industry. The book covers a range of important topics on pharmaceutical marketing, including an overview of the changing marketing strategies when a pharma company shifts from an acute base to a chronic therapy base, the increasing prevalence of chronic diseases, and the aging population in BRIC nations. It also presents a unique understanding of how feedback from customers in third-party applications can benefit and produce huge profit margins for pharma companies. It describes the benefits of the use of innovative technologies in pharma marketing and pharmacoeconomics, such as chatbots, online applications, sensors, symptom trackers, and virtual reality, which are being used in medical research, training, prevention, treatment, and diagnostics\"-- Provided by publisher." ] ;
    bf:supplementaryContent <http://id.loc.gov/vocabulary/msupplcont/bibliography>,
        <http://id.loc.gov/vocabulary/msupplcont/index> ;
    bf:tableOfContents [ a bf:TableOfContents ;
            rdfs:label "Overview of the Pharmaceutical Marketplace / Phool Chandra, Prashant Kumar, Surya Nath Pandey, Rashmi Pathak, Himanshu Sharma, and NeetuSachan -- Big Pharma and BRIC Health Systems : Policy and Management Dilemma / Prince and Rishabha Malviya -- Affiliate Marketing and the Symbiotic Relationship in the Pharma Industry / Jayanta Banerjee, Prabha Kiran, Vasudevan M., Aad Krishna Kishore Sv -- Empathic Innovation in the Healthcare Industry / Neta Kela -- Recent Trends in the Knowledge-Based Economy of Patents / Rishav Sharma, Rishabha Malviya, and Sonali Sundram -- The Implications of Pharmacoeconomics in Pharmaceutical Manufacturing / Ruchi Singh, Bhuneshwar Dutta Tripathi, Omsatyam, Binalkumari Somabhai Solanki, and AnkitaMoharana -- Overview of the Marketing Strategies Adopted by Different PharmaceuticalCompanies / Pankaj Kumar, Rahil Yusuf Zai, and Pramod Kumar Srivastava -- Role of Patents in Economic Development and Integration / Rishav Sharma, Rishabha Malviya, Swati Verma, Arvind Kumar, and Dhanalekshmi U. Meenakshi -- The Environment of Marketing Management in Transitory Businesses / Shubham Kakran, Arpit Sidhu, Abhimanyu, and Ashish Kumar -- Clinical Trials for Drugs : Pharmacoeconomics's Function and Their Emerging Effective Outcomes / Lakshita Rao, Neha Rai, Deepika Yadav, and Pawan Jalwal -- The Implications of Pharma Marketing to Improve Return on Investment (ROI) / Deepika Yadav, Rishabha Malviya, Arvind Kumar, and Neeraj Fuloria -- Government Healthcare Initiatives and the Demand for Pharmaceuticals / Ashish Kumar, Upendra Pratap Singh, Arpit Sidhu, and Shubham Kakran -- Looking Forward to the Future of Pharma Marketing and Pharmacoeconomics / Lovy Sharma, Disha Sharma, Sudhanshu Mishra, Mridani Tripathi, Smriti Ojha, and Sirisha Pingali -- Pharma Marketing in India : Prospects and Challenges / Rashmi Pathak, Himanshu Sharma, Neetu Sachan, and Phool Chandra -- Looking Forward Towards the Pharmacoeconomics and Pharma Marketing / Akanksha Sharma, Aditi Singh, and Rishabha Malviya." ] ;
    bf:title [ a bf:Title ;
            bf:mainTitle "Pharma marketing and pharmacoeconomics : opportunities, challenges, and the way forward" ] .